Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001

Wiedermann, U; Garner-Spitzer, E; Chao, Y; Maglakelidze, M; Bulat, I; Dechaphunkul, A; Arpornwirat, W; Charoentum, C; Yen, CJ; Yau, TC; Tanasanvimon, S; Maneechavakajorn, J; Sookprasert, A; Bai, LY; Chou, WC; Ungtrakul, T; Drinic, M; Tobias, J; Zielinski, CC; Chong, L; Ede, NJ; Marino, MT; Good, AJ

Wiedermann, U (corresponding author), Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Kinderspitalgasse 15, A-1090 Vienna, Austria.

CLINICAL CANCER RESEARCH, 2021; 27 (13): 3649

Abstract

Purpose: HER2/neu is overexpressed in up to 30% of gastroesophageal adenocarcinomas (GEA) and linked to poor prognosis. Recombinant mAbs to treat HER2......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索